Tactile Systems Technology, Inc. (NASDAQ:TCMD – Get Free Report) CFO Elaine M. Birkemeyer sold 3,778 shares of the firm’s stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $14.70, for a total transaction of $55,536.60. Following the completion of the transaction, the chief financial officer now directly owns 104,098 shares in the company, valued at approximately $1,530,240.60. This represents a 3.50 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.
Tactile Systems Technology Price Performance
Tactile Systems Technology stock opened at $14.62 on Wednesday. Tactile Systems Technology, Inc. has a 12-month low of $11.12 and a 12-month high of $21.10. The stock has a market cap of $344.81 million, a P/E ratio of 20.89 and a beta of 1.20. The company has a 50-day moving average price of $17.14 and a 200 day moving average price of $15.73. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.09. Tactile Systems Technology had a net margin of 5.79% and a return on equity of 9.37%. The firm had revenue of $85.59 million during the quarter, compared to analysts’ expectations of $85.39 million. Sell-side analysts anticipate that Tactile Systems Technology, Inc. will post 0.7 earnings per share for the current year.
Institutional Investors Weigh In On Tactile Systems Technology
Wall Street Analyst Weigh In
Several research firms have recently weighed in on TCMD. B. Riley downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $23.00 to $18.00 in a research note on Wednesday, February 19th. BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 5th. StockNews.com cut shares of Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research report on Thursday, January 16th. Finally, Oppenheimer cut shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th.
View Our Latest Research Report on Tactile Systems Technology
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Stories
- Five stocks we like better than Tactile Systems Technology
- Top Biotech Stocks: Exploring Innovation Opportunities
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Short Selling: How to Short a Stock
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Health Care Stocks Explained: Why You Might Want to Invest
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.